Stada-led €4bn loan spree could push lev pricing wider

By Victor Jimenez
31 Aug 2017

The European leveraged finance market is set to contend with loan deals approaching €4bn for the start of September. Over half of that is for the German pharmaceutical firm Stada — a deal that could help make funding more expensive for everyone else, writes Victor Jimenez.

“Every investor is waiting for the Stada loans,” said a leveraged finance banker in London.

Some of the bankers working on Stada, the flashiest and most anticipated deal in the European leveraged loan market for the second ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.